Filing Flows › Orthopediatrics (KIDS) › Scoliosis revenue
Orthopediatrics (KIDS) Scoliosis revenue by quarter
Orthopediatrics' Scoliosis revenue was $19.2M in Q3 2026 (third quarter 2026), +14% from Q2 2026. Over the last 6 quarters it ranged from $13.7M (Q1 2025) to $19.2M (Q3 2026).
| Quarter | Scoliosis revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $19.2M | +14% | +18% |
| Q2 2026 | $16.9M | +9% | -9% |
| Q1 2026 | $15.4M | -5% | +13% |
| Q3 2025 | $16.3M | -12% | — |
| Q2 2025 | $18.5M | +36% | — |
| Q1 2025 | $13.7M | — | — |
Q3 2026 at a glance
Orthopediatrics, Q3 2026: revenue $72.7M (+19% year over year), operating margin -5.8%, net loss $5.9M, operating cash flow $4.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Orthopediatrics' Scoliosis revenue?
Orthopediatrics' Scoliosis revenue was $19.2M in Q3 2026 (third quarter 2026), +14% from Q2 2026.
How has Orthopediatrics' Scoliosis revenue changed?
Over the last 6 quarters it ranged from $13.7M (Q1 2025) to $19.2M (Q3 2026).